Drug Patents owned by Bausch Lomb Ireland

1. List of Fluorescein Sodium And Benoxinate Hydrochloride drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10842872 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(14 years from now)

US10632197 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(14 years from now)

US10293047 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(14 years from now)

Drugs and Companies using BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM ingredient

Market Authorisation Date: 09 March, 2020

Treatment: Procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic.; Ocular examination, intraocular pressure measurement, or removal of foreign bodies or sutures, in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in